Advertisement

Annals of Hematology

, Volume 97, Issue 10, pp 1859–1868 | Cite as

Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales

  • Birgit Federmann
  • Martin R. Mueller
  • Julia Steinhilber
  • Marius S. Horger
  • Falko Fend
Original Article

Abstract

Development of diffuse large B-cell lymphoma in chronic lymphocytic leukemia, so-called Richter transformation (RT), occurs in 2–5% of patients and is associated with poor outcome. The clinical features of RT are fairly non-specific and unable to discriminate transformation from other mimics. In case of clinically suspected RT, a CT/MRT is recommended, and FDG-PET/CT may help to select the site of biopsy. Radiological features suggestive of RT have been defined, but there are only limited data about their predictive value, and histological confirmation is still considered the gold standard for RT diagnosis. We retrospectively analyzed 34 patients with clinically suspected RT and available radiological and histological data. A histopathological diagnosis of RT with concordant clinical and radiological findings was obtained in 13 patients. In 18 patients, CT did not show features of transformation, concordant with lack of RT in the biopsy. Of interest, a distinct lymphoma other than DLBCL was identified in two of these cases. A false-positive radiological diagnosis of RT was rendered in two patients, including a case of Herpes simplex virus lymphadenitis. In conclusion, our findings confirm the central role of tissue biopsy in the diagnostic work up in case of clinically suspected RT.

Keywords

CLL Richter syndrome Transformation CT Biopsy 

Notes

Funding information

BF is supported by the TÜFF-program, University of Tübingen (project 2320-0-0).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Tsimberidou AM, Keating MJ (2005) Richter syndrome: biology, incidence, and therapeutic strategies. Cancer 103:216–228CrossRefGoogle Scholar
  2. 2.
    Tsimberidou AM, Keating MJ (2006) Richter’s transformation in chronic lymphocytic leukemia. Semin Oncol 33:250–256CrossRefGoogle Scholar
  3. 3.
    Richter MN (1928) Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 4(285–92):7PubMedPubMedCentralGoogle Scholar
  4. 4.
    Rossi D, Gaidano G (2009) Richter syndrome: molecular insights and clinical perspectives. Hematol Oncol 27:1–10CrossRefGoogle Scholar
  5. 5.
    Parikh SA, Rabe KG, Call TG, Zent CS, Habermann TM, Ding W, Leis JF, Schwager SM, Hanson CA, Macon WR, Kay NE, Slager SL, Shanafelt TD (2013) Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients. Br J Haematol 162:774–782CrossRefGoogle Scholar
  6. 6.
    Rossi D, Cerri M, Capello D, Deambrogi C, Rossi FM, Zucchetto A, De Paoli L, Cresta S, Rasi S, Spina V, Franceschetti S, Lunghi M, Vendramin C, Bomben R, Ramponi A, Monga G, Conconi A, Magnani C, Gattei V, Gaidano G (2008) Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 142:202–215CrossRefGoogle Scholar
  7. 7.
    Parikh SA, Kay NE, Shanafelt TD (2014) How we treat Richter syndrome. Blood 123:1647–1657CrossRefGoogle Scholar
  8. 8.
    Rossi D (2016) Richter’s syndrome: novel and promising therapeutic alternatives. Best Pract Res Clin Haematol 29:30–39CrossRefGoogle Scholar
  9. 9.
    Chigrinova E, Rinaldi A, Kwee I, Rossi D, Rancoita PM, Strefford JC, Oscier D, Stamatopoulos K, Papadaki T, Berger F, Young KH, Murray F, Rosenquist R, Greiner TC, Chan WC, Orlandi EM, Lucioni M, Marasca R, Inghirami G, Ladetto M, Forconi F, Cogliatti S, Votavova H, Swerdlow SH, Stilgenbauer S, Piris MA, Matolcsy A, Spagnolo D, Nikitin E, Zamo A, Gattei V, Bhagat G, Ott G, Zucca E, Gaidano G, Bertoni F (2013) Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood 122:2673–2682CrossRefGoogle Scholar
  10. 10.
    Fabbri G, Khiabanian H, Holmes AB, Wang J, Messina M, Mullighan CG, Pasqualucci L, Rabadan R, Dalla-Favera R (2013) Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J Exp Med 210:2273–2288CrossRefGoogle Scholar
  11. 11.
    Campo E, Ghia P, Montserrat E (2017) In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (eds) WHO classification of tumours of hematopoietic and lymphoid tissues, revised Fourth Edition, pp 216–221Google Scholar
  12. 12.
    Agbay RL, Jain N, Loghavi S, Medeiros LJ, Khoury JD (2016) Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 91:1036–1043CrossRefGoogle Scholar
  13. 13.
    Langerbeins P, Busch R, Anheier N, Durig J, Bergmann M, Goebeler ME, Hurtz HJ, Stauch MB, Stilgenbauer S, Dohner H, Fink AM, Cramer P, Fischer K, Wendtner CM, Hallek M, Eichhorst B (2014) Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation. Am J Hematol 89:E239–E243CrossRefGoogle Scholar
  14. 14.
    Furman RR, Sharman JP, Coutre SE, Cheson BD, Pagel JM, Hillmen P, Barrientos JC, Zelenetz AD, Kipps TJ, Flinn I, Ghia P, Eradat H, Ervin T, Lamanna N, Coiffier B, Pettitt AR, Ma S, Stilgenbauer S, Cramer P, Aiello M, Johnson DM, Miller LL, Li D, Jahn TM, Dansey RD, Hallek M, O'Brien SM (2014) Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N Engl J Med 370:997–1007CrossRefGoogle Scholar
  15. 15.
    Roberts AW, Davids MS, Pagel JM, Kahl BS, Puvvada SD, Gerecitano JF, Kipps TJ, Anderson MA, Brown JR, Gressick L, Wong S, Dunbar M, Zhu M, Desai MB, Cerri E, Heitner Enschede S, Humerickhouse RA, Wierda WG, Seymour JF (2016) Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia. N Engl J Med 374:311–322CrossRefGoogle Scholar
  16. 16.
    O'Brien S, Furman RR, Coutre SE, Sharman JP, Burger JA, Blum KA, Grant B, Richards DA, Coleman M, Wierda WG, Jones JA, Zhao W, Heerema NA, Johnson AJ, Izumi R, Hamdy A, Chang BY, Graef T, Clow F, Buggy JJ, James DF, Byrd JC (2014) Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial. Lancet Oncol 15:48–58CrossRefGoogle Scholar
  17. 17.
    Jain P, Keating M, Wierda W, Estrov Z, Ferrajoli A, Jain N, George B, James D, Kantarjian H, Burger J, O'Brien S (2015) Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib. Blood 125:2062–2067CrossRefGoogle Scholar
  18. 18.
    Bruzzi JF, Macapinlac H, Tsimberidou AM, Truong MT, Keating MJ, Marom EM, Munden RF (2006) Detection of Richter’s transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med 47:1267–1273Google Scholar
  19. 19.
    Falchi L, Keating MJ, Marom EM, Truong MT, Schlette EJ, Sargent RL, Trinh L, Wang X, Smith SC, Jain N, Estrov Z, O'Brien S, Wierda WG, Lerner S, Ferrajoli A (2014) Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia. Blood 123:2783–2790CrossRefGoogle Scholar
  20. 20.
    Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, Keating MJ, Montserrat E, Rai KR, Kipps TJ (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 111:5446–5456CrossRefGoogle Scholar
  21. 21.
    Gine E, Martinez A, Villamor N, Lopez-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X, Muntanola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E, Montserrat E (2010) Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 95:1526–1533CrossRefGoogle Scholar
  22. 22.
    Kazmierczak M, Kroll-Balcerzak R, Balcerzak A, Czechowska E, Gil L, Sawinski K, Szczepaniak A, Komarnicki M (2014) Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion. Med Oncol 31:800–808CrossRefGoogle Scholar
  23. 23.
    Pugh WC, Manning JT, Butler JJ (1988) Paraimmunoblastic variant of small lymphocytic lymphoma/leukemia. Am J Surg Pathol 12:907–917CrossRefGoogle Scholar
  24. 24.
    Espinet B, Larriba I, Salido M, Florensa L, Woessner S, Sans-Sabrafen J, Barranco C, Serrano S, Sole F (2002) Genetic characterization of the paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia: a case report and review of the literature. Hum Pathol 33:1145–1148CrossRefGoogle Scholar
  25. 25.
    Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K, Arcaini L, Lucioni M, Rocque GB, Xu-Monette ZY, Visco C, Chang J, Chigrinova E, Forconi F, Marasca R, Besson C, Papadaki T, Paulli M, Larocca LM, Pileri SA, Gattei V, Bertoni F, Foa R, Young KH, Gaidano G (2011) The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 117:3391–3401CrossRefGoogle Scholar
  26. 26.
    Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275–282CrossRefGoogle Scholar
  27. 27.
    Mauro FR, Chauvie S, Paoloni F, Biggi A, Cimino G, Rago A, Gentile M, Morabito F, Coscia M, Bello M, Sacchetti GM, Rossi D, Laurenti L, Autore F, Campanelli M, Trastulli F, Nicolai E, Riminucci M, Gaidano G, Guarini A, Gallamini A, Foa R (2015) Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. Leukemia 29:1360–1365CrossRefGoogle Scholar
  28. 28.
    Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, Burek C, Hartmann E, Rudiger T, Jaffe ES, Muller-Hermelink HK, Ott G, Fend F, Rosenwald A (2007) IgVH mutational status and clonality analysis of Richter’s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 31:1605–1614CrossRefGoogle Scholar
  29. 29.
    Scandurra M, Rossi D, Deambrogi C, Rancoita PM, Chigrinova E, Mian M, Cerri M, Rasi S, Sozzi E, Forconi F, Ponzoni M, Moreno SM, Piris MA, Inghirami G, Zucca E, Gattei V, Rinaldi A, Kwee I, Gaidano G, Bertoni F (2010) Genomic profiling of Richter’s syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas. Hematol Oncol 28:62–67CrossRefGoogle Scholar
  30. 30.
    Forconi F, Moss P (2015) Perturbation of the normal immune system in patients with CLL. Blood 126:573–581CrossRefGoogle Scholar
  31. 31.
    Jain P, Burger J, Khoury JD (2017) CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferation. Am J Hematol 141:1113–1114CrossRefGoogle Scholar
  32. 32.
    Papajik T, Myslivecek M, Urbanova R, Buriankova E, Kapitanova Z, Prochazka V, Turcsanyi P, Formanek R, Henzlova L, Flodr P, Jarosova M, Indrak K (2014) 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation. Leuk Lymphoma 55:314–319CrossRefGoogle Scholar
  33. 33.
    Conte MJ, Bowen DA, Wiseman GA, Rabe KG, Slager SL, Schwager SM, Call TG, Viswanatha DS, Zent CS (2014) Use of positron emission tomography-computed tomography in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 55:2079–2084CrossRefGoogle Scholar
  34. 34.
    Pemmaraju N, Jain P, Medeiros LJ, Jorgenson JL, Jain N, Willis J, Kontoyiannis DP, Estrov Z, Wierda WG (2017) PET-positive lymphadenopathy in CLL-Not always Richter transformation. Am J Hematol 92:405–406CrossRefGoogle Scholar
  35. 35.
    Salem A, Loghavi S, Khoury JD, Agbay RL, Jorgensen JL, Medeiros LJ (2017) Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature. Histopathology 70:821–831CrossRefGoogle Scholar
  36. 36.
    Jain P, Hu S, Jabbour E, Takahashi K, Pemmaraju N, O'Brien S, Mulanovich VE, Estrov Z (2015) Disseminated histoplasmosis as pseudo Richter’s transformation in a patient with chronic lymphocytic leukemia. Am J Hematol 90:752–753CrossRefGoogle Scholar
  37. 37.
    Parikh SA, Bhusal Y, Faderl SH, Wierda WG, O'Brien S, Kantarjian H, Adachi JA, Burger JA (2010) The great imitator: systemic nocardiosis mimicking Richter’s transformation in relapsed chronic lymphocytic leukemia. J Clin Oncol 28:e732–e734CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Birgit Federmann
    • 1
  • Martin R. Mueller
    • 2
  • Julia Steinhilber
    • 1
  • Marius S. Horger
    • 3
  • Falko Fend
    • 1
  1. 1.Institute of Pathology and NeuropathologyUniversity Hospital and Comprehensive Cancer Center Tübingen, University of TübingenTübingenGermany
  2. 2.Department of Hematology and OncologyUniversity Hospital and Comprehensive Cancer Center Tübingen, University of TübingenTübingenGermany
  3. 3.Department of RadiologyUniversity Hospital and Comprehensive Cancer Center Tübingen, University of TübingenTübingenGermany

Personalised recommendations